SCHEMBL10101479

SCHEMBL10101479

C[C@H]1[C@@H](F)[C@H](c2ccc3c(N)nc(N)nn23)O[C@@H]1CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10101555 1.00 — —
SCHEMBL10101554 0.87 CYP2C19 (0.36) —
SCHEMBL10101549 0.82 POLRMT (0.36) —
SCHEMBL10101489 0.82 POLRMT (0.36) —
SCHEMBL4765508 0.80 — —
SCHEMBL4765542 0.80 — —
SCHEMBL30873319 0.77 HIF1A (0.41) —
SCHEMBL807421 0.77 HIF1A (0.41) —
SCHEMBL18380007 0.77 HIF1A (0.41) —
SCHEMBL10101483 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119607-B2 Bicyclic nucleosides and nucleotides as therapeutic agents BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2012-02-21 — — US disclosed
US-20100035836-A1 BICYCLIC NUCLEOSIDES AND NUCLEOTIDES AS THERAPEUTIC AGENTS BIOTA SCIENTIFIC MANAGEMENT (AU) 2010-02-11 — — US disclosed
Send feedback